Jimmy, I do agree that a democratic process is needed to select the BODs. In fact, the process is mandated by the company Bylaws. Now that a new slate of candidates has been put forth, we should be hearing from the current Board as to who their candidates will be.
BTW, nobody on any of the MBs or Social Media Platforms has provided documentation and/or validation of the harsh and critical assessments of the intentions of the candidates nominated by the 13D Nominating Group. As in any election, the candidates themselves will have to make the case to garner votes. Shareholders can vote for individuals or the entire slate, as they choose. Let's get the best five people on the BODs who can set in motion a credible pathway to Leronlimab's FDA Approval for HIV and Cancer. When that Approval is received, everything should fall in place for all stakeholders. I am looking forward to learning more about each candidate on both sides.
News 
Market Data 
Discover 
